The BigPharma Alternative or BPA –
join the movement
!
Our email address: bartsmsblog[at]gmail.com
Pages
Home
About
Who
Team
Publications
Trials
Conflicts
Contact
Charcot Project
Grand Challenges
Articles of Interest
Jargon or Glossary
4th Research Day
Monday, 17 January 2011
Genzyme details market potential of Alemtuzumab for MS
Wow! Let's hope it is not too expensive for the NHS.
Click here to read the press release!
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment